Figure 2: PMCA2 is expressed most highly in Basal-like breast cancer.

Log2 row-mean centred RSEM data sourced from the TCGA consortium. (A–C), expression for PMCA2, PMCA1 and PMCA4, respectively. Significance was found through a one-way ANOVA with a Tukey’s multiple comparisons test, ****P < 0.0001 between the Basal-like tumors and HER2, LumA and LumB.